Grants and Contributions:
Title:
ARP - Development of a three-component cell culture kit for cancer drug development
Agreement Number:
981343
Agreement Value:
$50,000.00
Agreement Date:
Nov 8, 2021 - Mar 31, 2022
Description:
Development of a minimum viable product (MVP) of a complete 3D cell culture model of cancer. This includes three components: a non-toxic cell dyes for cell analysis, a hydrogel for three-dimensional cell growth, and supplement for cell culture medium.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Quebec, Quebec, CA G1W 2G7
Reference Number:
172-2021-2022-Q3-981343
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
718552334
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by -30 days.
Amendment Date
Jan 6, 2022
Recipient's Legal Name:
Saguaro Technologies inc.
Federal Riding Name:
Louis-Hébert
Federal Riding Number:
24044
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: